微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 33.49% | 69.15% | 9.05% | 113/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 30.71% | 128.61% | -1.22% | 117/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 31.09% | 530.82% | 7.22% | 116/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 29% | 55.84% | 46.45% | 124/160 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 19.8% | 100.73% | 47.39% | 140/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 13.43% | 1461.27% | 286.15% | 144/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | -7.22% | 82.24% | -138.79% | 144/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 18.61% | 161.12% | 88.64% | 145/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 9.86% | 172.85% | 1099.49% | 139/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | -0.99% | 95.63% | 97.57% | 147/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | -40.64% | 26.78% | -33.51% | 136/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | -30.44% | -265.26% | -124.83% | 150/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | -13.54% | -972.26% | 40.08% | 133/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | -22.59% | 69.33% | 59.29% | 141/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | -55.5% | 70.88% | -401.34% | 123/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 18.42% | 136.93% | 1086.71% | 141/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 1.55% | 2% | 102.11% | 118/160 | 56.57% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | -73.67% | 2% | -47.73% | 129/160 | 54.32% | 微芯生物 | 95.14% | 行业排名> |
| 2019-12-31 | -49.87% | 90.54% | 73.83% | 136/160 | -1204.25% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-03-31 | -190.59% | 2% | 63.86% | 107/160 | 51.37% | 微芯生物 | 95.81% | 行业排名> |
| 2018-12-31 | -527.32% | -656.91% | -656.91% | 133/160 | -205.91% | 微芯生物 | 96.09% | 行业排名> |
| 2015-12-31 | 94.69% | 30.12% | 30.12% | 2/160 | 46.24% | 微芯生物 | 96.11% | 行业排名> |